Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation

Published:2010-01 Issue:1 Volume:52 Page:88-95
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Chen Kuen-Feng,Yu Hui-Chuan,Liu Tsung-Hao,Lee Shoei-Sheng,Chen Pei-Jer,Cheng Ann-Lii

Funder

National Taiwan University Hospital

National Science Council, Taiwan

Department of Health, Executive Yuan, Taiwan

Publisher

Elsevier BV

Subject

Hepatology

Reference27 articles.

1. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008;Verslype;Ann Oncol,2009

2. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

3. The proteasome and proteasome inhibitors in cancer therapy;Voorhees;Annu Rev Pharmacol Toxicol,2006

4. New drugs in multiple myeloma: mechanisms of action and phase I/II clinical findings;Ocio;Lancet Oncol,2008

5. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells;Chen;Cancer Res,2008

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and Future States of Natural Killer Cell-Based Immunotherapy in Hepatocellular Carcinoma;Critical Reviews in Immunology;2024

2. The role of proteasomes in tumorigenesis;Genes & Diseases;2023-08

3. The molecular genetics of PI3K/PTEN/AKT/mTOR pathway in the malformations of cortical development;Genes & Diseases;2023-07

4. Effect of Lenvatinib treatment on the cell cycle and microRNA profile in hepatocellular carcinoma cells;Biomedical Reports;2022-08-03

5. Broad Transcriptomic Impact of Sorafenib and Its Relation to the Antitumoral Properties in Liver Cancer Cells;Cancers;2022-02-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3